El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
AmerisourceBergen Corporation
Cerrado
SectorSalud
0
Resumen
Variación precio
24h
Mínimo
Máximo
Ingresos | 906M 566M |
|---|---|
Ventas | 2.2B 86B |
P/B Media del Sector | 43.486 61.417 |
BPA | 4.08 |
Rentabilidad por dividendo | 0.63 |
Margen de beneficio | 0.659 |
Empleados | 47,000 |
EBITDA | 858M 1B |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +17.46% upside |
Rentabilidad por dividendo Media del Sector | 0.63% 2.40% |
|---|---|
Próximas Ganancias | 6 may 2026 |
Fecha Próximo Dividendo | 1 jun 2026 |
Próxima Fecha de Ex Dividendo | 15 may 2026 |
Capitalización de Mercado | -341M 70B |
|---|---|
Apertura anterior | 0 |
Cierre anterior | 0 |
Noticias sobre sentimiento de mercado
By Acuity
15%
85%
11 / 351 Clasificación en Healthcare
AmerisourceBergen Corporation Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
AmerisourceBergen Corporation Esperado
Precio Objetivo
By TipRanks
17.46% repunte
Estimación a 12 meses
Media 414.22 USD 17.46%
Máximo 440 USD
Mínimo 380 USD
De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AmerisourceBergen Corporation Dist en los últimos 3 meses.
Sentimiento
By Acuity
11 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista notoria
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de AmerisourceBergen Corporation
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Live chat